Paul M. George
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Paul M. George has a total of 168 co-authors. Here are the top co-authors by number of shared publications:
Byeongtaek Oh
Department of Neurology and Neurological Sciences Stanford University School of Medicine 300 Pasteur Dr., MC5778 Stanford CA 94305 USA
8 shared publications- Shang Song
Department of Biomedical Engineering, The University of Arizona, Tucson, USA
7 shared publications Alexa Levinson
Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, USA
5 shared publicationsSruthi Santhanam
Department of Neurology and Neurological Sciences Stanford University School of Medicine 300 Pasteur Dr., MC5778 Stanford CA 94305 USA
5 shared publications- David A. LaVan
Materials Measurement Science Division, Material Measurement Laboratory, National Institute of Standards and Technology 1 , Gaithersburg, Maryland 20899
4 shared publications - Gary Kenneth Steinberg
Department of Neurosurgery, Stanford University School of Medicine, Stanford, California, USA
4 shared publications
Latest Publications
- Open Access
- 14 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Direct and capacitive electrical stimulation shapes neural progenitor cell survival and orientation on conductive scaffolds
Electrical stimulation (ES) of neural progenitor cells (NPCs) on conductive biomaterials offers a promising strategy to enhance regenerative therapies for neurological disorders. In this study, we designed and evaluated two ES platforms, direct and capacitively coupled, using silver nanowire-integrated collagen scaffolds to investigate their effects on NPC orientation and viability. Direct stimulation promoted NPC alignment along the electric field, suggesting enhanced guidance potential for neural repair. In contrast, the capacitively coupled system did not alter cell morphology but improved viability by 3.8-fold (cells parallel to the electric field) and 2.1-fold (perpendicular) relative to controls, highlighting a safer, non-contact method to support cell survival. Importantly, in vivo implantation of the conductive biomaterial in a rodent stroke model did not appear to elevate astrocytic activation, supporting its biocompatibility within an injury-compromised brain environment. These findings reveal distinct advantages of each stimulation modality, the preference of NPCs to be aligned parallel to the applied electric field in both systems, and underscore the therapeutic potential of tuning electrical environments for NPC support.
- 14 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessDirect and capacitive electrical stimulation shapes neural progenitor cell survival and orientation on conductive scaffolds
Electrical stimulation (ES) of neural progenitor cells (NPCs) on conductive biomaterials offers a promising strategy to enhance regenerative therapies for neurological disorders. In this study, we designed and evaluated two ES platforms, direct and capacitively coupled, using silver nanowire-integrated collagen scaffolds to investigate their effects on NPC orientation and viability. Direct stimulation promoted NPC alignment along the electric field, suggesting enhanced guidance potential for neural repair. In contrast, the capacitively coupled system did not alter cell morphology but improved viability by 3.8-fold (cells parallel to the electric field) and 2.1-fold (perpendicular) relative to controls, highlighting a safer, non-contact method to support cell survival. Importantly, in vivo implantation of the conductive biomaterial in a rodent stroke model did not appear to elevate astrocytic activation, supporting its biocompatibility within an injury-compromised brain environment. These findings reveal distinct advantages of each stimulation modality, the preference of NPCs to be aligned parallel to the applied electric field in both systems, and underscore the therapeutic potential of tuning electrical environments for NPC support.
- Open Access
- 10 November 2025
- Published by Springer Nature in Nature Biotechnology
- Vol. 44 (8) , 1-12
Clearance of intracranial debris by ultrasound reduces inflammation and improves outcomes in hemorrhagic stroke models
Impaired clearance of neurotoxic debris in the brain exacerbates neurologic disease and presents a promising therapeutic target. Pharmacologic therapies can enhance meningeal lymphatic clearance in preclinical models but may be limited by systemic toxicities or invasive administration. Here we report a low-intensity, focused ultrasound protocol that noninvasively clears pathogenic substances from the cerebrospinal fluid and brain interstitium in mice. Using two models of hemorrhagic stroke, we demonstrate that this protocol clears the cerebrospinal fluid and interstitium of blood cells, which accumulate in the deep cervical lymph nodes via meningeal lymphatics. The protocol directly modulates molecular processes, including mechanosensitive channels, to shift microglial phenotypes and astrocytic aquaporin localization to reduce neuroinflammation and neurocytotoxicity. In the intracerebral hemorrhage model, it improves behavioral outcomes and increases survival with greater efficacy than a pharmacologic benchmark. The protocol satisfies Food and Drug Administration safety guidelines, supporting clinical translatability. If demonstrated effective clinically, it may provide therapeutic benefit not only in hemorrhagic stroke but also in other neurologic disorders that involve impaired debris clearance.
- 10 November 2025
- Published by Springer Nature in Nature Biotechnology
- Vol. 44 (8) , 1-12
Open AccessClearance of intracranial debris by ultrasound reduces inflammation and improves outcomes in hemorrhagic stroke models
Impaired clearance of neurotoxic debris in the brain exacerbates neurologic disease and presents a promising therapeutic target. Pharmacologic therapies can enhance meningeal lymphatic clearance in preclinical models but may be limited by systemic toxicities or invasive administration. Here we report a low-intensity, focused ultrasound protocol that noninvasively clears pathogenic substances from the cerebrospinal fluid and brain interstitium in mice. Using two models of hemorrhagic stroke, we demonstrate that this protocol clears the cerebrospinal fluid and interstitium of blood cells, which accumulate in the deep cervical lymph nodes via meningeal lymphatics. The protocol directly modulates molecular processes, including mechanosensitive channels, to shift microglial phenotypes and astrocytic aquaporin localization to reduce neuroinflammation and neurocytotoxicity. In the intracerebral hemorrhage model, it improves behavioral outcomes and increases survival with greater efficacy than a pharmacologic benchmark. The protocol satisfies Food and Drug Administration safety guidelines, supporting clinical translatability. If demonstrated effective clinically, it may provide therapeutic benefit not only in hemorrhagic stroke but also in other neurologic disorders that involve impaired debris clearance.
- 1 November 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (11)
Preclinical Evidence of Nogo-A Inhibition in Stroke Recovery: A Scoping Review
Stroke is one of the leading causes of disability worldwide. Although preclinical studies have shown promising results of pharmacotherapies to enhance stroke recovery, no drug has been approved for stroke recovery in patients. In this article, we review the preclinical data of one promising treatment, inhibition of NgR1 (Nogo receptor 1) signaling, for stroke recovery. Our scoping review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Extension for Scoping Reviews and surveyed the peer-reviewed literature on PubMed and citation searching. Studies were eligible if they evaluated the pharmacological inhibition of Nogo/NgR1 signaling in nonhuman models of stroke assessing sensorimotor or functional outcomes. There were no restrictions in years considered. An assessment of the risk of bias was performed using the Systematic Review center for Laboratory Animal Experimentation tool. Three hundred seventeen articles were screened based on the inclusion criteria. Thirty preclinical studies were included. Most studies (90%) were conducted in rodents, with only 3 studies (10%) completed in nonhuman primates. Anti-Nogo-A antibody was the most common pharmacological intervention, used in 21 (70%) studies. Most preclinical studies delivered the study drug directly into the central nervous system (intrathecal, intraventricular, or intraparenchymal), with far fewer studies (n=5) testing subcutaneous, intravenous, or intranasal administration. Among the 30 studies included, 27 (90%) report a beneficial effect. In conclusion, there is a large body of preclinical evidence to support Nogo/NgR1 inhibition in promoting stroke recovery. A clinical trial to assess the safety, feasibility, and efficacy among patients with stroke is warranted.
- 1 November 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (11)
Preclinical Evidence of Nogo-A Inhibition in Stroke Recovery: A Scoping Review
Stroke is one of the leading causes of disability worldwide. Although preclinical studies have shown promising results of pharmacotherapies to enhance stroke recovery, no drug has been approved for stroke recovery in patients. In this article, we review the preclinical data of one promising treatment, inhibition of NgR1 (Nogo receptor 1) signaling, for stroke recovery. Our scoping review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Extension for Scoping Reviews and surveyed the peer-reviewed literature on PubMed and citation searching. Studies were eligible if they evaluated the pharmacological inhibition of Nogo/NgR1 signaling in nonhuman models of stroke assessing sensorimotor or functional outcomes. There were no restrictions in years considered. An assessment of the risk of bias was performed using the Systematic Review center for Laboratory Animal Experimentation tool. Three hundred seventeen articles were screened based on the inclusion criteria. Thirty preclinical studies were included. Most studies (90%) were conducted in rodents, with only 3 studies (10%) completed in nonhuman primates. Anti-Nogo-A antibody was the most common pharmacological intervention, used in 21 (70%) studies. Most preclinical studies delivered the study drug directly into the central nervous system (intrathecal, intraventricular, or intraparenchymal), with far fewer studies (n=5) testing subcutaneous, intravenous, or intranasal administration. Among the 30 studies included, 27 (90%) report a beneficial effect. In conclusion, there is a large body of preclinical evidence to support Nogo/NgR1 inhibition in promoting stroke recovery. A clinical trial to assess the safety, feasibility, and efficacy among patients with stroke is warranted.
- Top Cited Papers
- 2 June 2025
- Published by Springer Nature in Nature Neuroscience
- Vol. 28 (6) , 1130-1145
Changing genes, cells and networks to reprogram the brain after stroke
Important advances have been made in reperfusion therapies for acute ischemic stroke. However, a majority of patients are either ineligible for or do not respond to treatments and continue to have considerable functional deficits. Stroke results in a pathological disruption of the neurovascular unit (NVU) that involves blood–brain barrier leakage, glial activation, neuronal damage and chronic inflammation, all of which create a microenvironment that hinders recovery. Therefore, finding ways to promote central nervous system recovery remains the holy grail of stroke research. Here we propose a conceptual framework to synthesize recent progress in the field, which is currently dispersed and disconnected in the literature. We suggest that stroke recovery requires an integrated reprogramming process throughout the brain that occurs at multiple levels, including changes in gene expression, endogenous cellular transdifferentiation within the NVU, and reorganization of larger-scale neural and social networks.
- 2 June 2025
- Published by Springer Nature in Nature Neuroscience
- Vol. 28 (6) , 1130-1145
Top Cited PapersChanging genes, cells and networks to reprogram the brain after stroke
Important advances have been made in reperfusion therapies for acute ischemic stroke. However, a majority of patients are either ineligible for or do not respond to treatments and continue to have considerable functional deficits. Stroke results in a pathological disruption of the neurovascular unit (NVU) that involves blood–brain barrier leakage, glial activation, neuronal damage and chronic inflammation, all of which create a microenvironment that hinders recovery. Therefore, finding ways to promote central nervous system recovery remains the holy grail of stroke research. Here we propose a conceptual framework to synthesize recent progress in the field, which is currently dispersed and disconnected in the literature. We suggest that stroke recovery requires an integrated reprogramming process throughout the brain that occurs at multiple levels, including changes in gene expression, endogenous cellular transdifferentiation within the NVU, and reorganization of larger-scale neural and social networks.
- 1 June 2024
- Published by Wolters Kluwer Health in Stroke
- Vol. 55 (6) , e165-e168
Eye Toward Stroke Prevention: Central Retinal Artery Occlusion and Tandem Internal Carotid Artery Occlusion
- 1 June 2024
- Published by Wolters Kluwer Health in Stroke
- Vol. 55 (6) , e165-e168
Eye Toward Stroke Prevention: Central Retinal Artery Occlusion and Tandem Internal Carotid Artery Occlusion
- 1 March 2024
- Published by Wolters Kluwer Health in Stroke
- Vol. 55 (3) , E56-E60
Intravenous Tenecteplase and Carotid Artery Stenting in a Young Adult With Fibromuscular Dysplasia and Carotid Dissection
- 1 March 2024
- Published by Wolters Kluwer Health in Stroke
- Vol. 55 (3) , E56-E60
Intravenous Tenecteplase and Carotid Artery Stenting in a Young Adult With Fibromuscular Dysplasia and Carotid Dissection
- Open Access
- 30 July 2023
- Published by Wiley in Advanced Electronic Materials
- Vol. 9 (10) , 1-25
Wirelessly Powered‐Electrically Conductive Polymer System for Stem Cell Enhanced Stroke Recovery
Effective stroke recovery therapeutics remain limited. Stem cell therapies have yielded promising results, but the harsh ischemic environment of the post‐stroke brain reduces their therapeutic potential. Previously, a conductive polymer system that enables stem cell delivery with simultaneous electrical modulation of the cells and surrounding neural environment is developed. This wired conductive polymer system proved efficacious in optimizing ideal conditions for stem cell mediated motor improvements in a rodent model of stroke. To further enable preclinical studies and enhance translational potential, a method to improve this system by eliminating its dependence upon a tethered power source is identified. A wirelessly powered, electrically conductive polymer system that eases therapeutic application and enables full mobility is herein developed. As a proof of concept, it is demonstrated that the wirelessly powered system is able to stimulate neural stem cells in vitro, as well as in vivo in a rodent model of stroke. This system modulates the stroke microenvironment and increases the production of endogenous stem cells. In summation, this novel, wirelessly powered conductive polymer system can serve as a mobile platform for a wide variety of therapeutics involving electrical stimulation.
- 30 July 2023
- Published by Wiley in Advanced Electronic Materials
- Vol. 9 (10) , 1-25
Open AccessWirelessly Powered‐Electrically Conductive Polymer System for Stem Cell Enhanced Stroke Recovery
Effective stroke recovery therapeutics remain limited. Stem cell therapies have yielded promising results, but the harsh ischemic environment of the post‐stroke brain reduces their therapeutic potential. Previously, a conductive polymer system that enables stem cell delivery with simultaneous electrical modulation of the cells and surrounding neural environment is developed. This wired conductive polymer system proved efficacious in optimizing ideal conditions for stem cell mediated motor improvements in a rodent model of stroke. To further enable preclinical studies and enhance translational potential, a method to improve this system by eliminating its dependence upon a tethered power source is identified. A wirelessly powered, electrically conductive polymer system that eases therapeutic application and enables full mobility is herein developed. As a proof of concept, it is demonstrated that the wirelessly powered system is able to stimulate neural stem cells in vitro, as well as in vivo in a rodent model of stroke. This system modulates the stroke microenvironment and increases the production of endogenous stem cells. In summation, this novel, wirelessly powered conductive polymer system can serve as a mobile platform for a wide variety of therapeutics involving electrical stimulation.
- 8 June 2023
- Published by SAGE Publications in The Neurohospitalist
- Vol. 13 (4) , 394-398
Clinical Problem Solving: A 38-year-Old Woman With Systemic Lupus Erythematosus Presenting With Headache, Nausea, and Vomiting
A 38-year-old woman with migraine headaches and systemic lupus erythematosus with recent cessation of her immunosuppressive therapy presents with prolonged headache and hypertensive emergency. Her examination is notable for a peripheral right facial palsy and stable malar rash. There are no signs of systemic infection nor systemic symptoms of a lupus flare. Initial CT head reveals bilateral hypodensities in the basal ganglia. Within 8 hours of presentation, she develops right hemiplegia and becomes encephalopathic. MRI shows multifocal acute infarcts (most notably in the left basal ganglia), enhancement of the right facial nerve, and multifocal vessel wall enhancement in the anterior and posterior circulation. We discuss the differential diagnosis, comprehensive workup, and subsequent treatment decisions in the management of this immunocompromised patient with encephalopathy, headache, and rapidly progressing focal neurologic deficits.
- 8 June 2023
- Published by SAGE Publications in The Neurohospitalist
- Vol. 13 (4) , 394-398
Clinical Problem Solving: A 38-year-Old Woman With Systemic Lupus Erythematosus Presenting With Headache, Nausea, and Vomiting
A 38-year-old woman with migraine headaches and systemic lupus erythematosus with recent cessation of her immunosuppressive therapy presents with prolonged headache and hypertensive emergency. Her examination is notable for a peripheral right facial palsy and stable malar rash. There are no signs of systemic infection nor systemic symptoms of a lupus flare. Initial CT head reveals bilateral hypodensities in the basal ganglia. Within 8 hours of presentation, she develops right hemiplegia and becomes encephalopathic. MRI shows multifocal acute infarcts (most notably in the left basal ganglia), enhancement of the right facial nerve, and multifocal vessel wall enhancement in the anterior and posterior circulation. We discuss the differential diagnosis, comprehensive workup, and subsequent treatment decisions in the management of this immunocompromised patient with encephalopathy, headache, and rapidly progressing focal neurologic deficits.
- 28 February 2023
- Published by Wiley in Advanced Materials Technologies
- Vol. 8 (10)
Controlling the Stem Cell Environment Via Conducting Polymer Hydrogels to Enhance Therapeutic Potential
Stem cells are a promising treatment option for various neurological diseases such as stroke, spinal cord injury, and other neurodegenerative disorders. However, the ideal environment to optimize the therapeutic potential of the cells remains poorly understood. Stem cells in the native environment are influenced by a combination of mechanical, chemical, and electrical cues for proliferation and differentiation. Because of their controllable properties, conductive hydrogels are promising biomaterials to interact with stem cells. Herein, this work develops an interpenetrating conducting polymer hydrogel with tunable mechanical properties. The hydrogel serves as a platform to provide mechanical and electrical cues for interactions with mesenchymal stem cells (MSCs). This work optimizes the formulation of the hydrogel for maximum viability of MSCs and relatively higher cytoskeletal protein expression. The viability of cells is not affected due to electrical stimulation (ES). Further, ES alters the trophic factor secretion of MSCs, with significant increase in VEGF pathway genes—VEGFA and HSPB1. In addition, substrate stiffness of the hydrogel enhances the VEGFB secretion compared to control. Hence, the conducting polymer hydrogel system creates a tunable physical and electrical niche to enhance the therapeutic potential of stem cells for neurological injuries.
- 28 February 2023
- Published by Wiley in Advanced Materials Technologies
- Vol. 8 (10)
Controlling the Stem Cell Environment Via Conducting Polymer Hydrogels to Enhance Therapeutic Potential
Stem cells are a promising treatment option for various neurological diseases such as stroke, spinal cord injury, and other neurodegenerative disorders. However, the ideal environment to optimize the therapeutic potential of the cells remains poorly understood. Stem cells in the native environment are influenced by a combination of mechanical, chemical, and electrical cues for proliferation and differentiation. Because of their controllable properties, conductive hydrogels are promising biomaterials to interact with stem cells. Herein, this work develops an interpenetrating conducting polymer hydrogel with tunable mechanical properties. The hydrogel serves as a platform to provide mechanical and electrical cues for interactions with mesenchymal stem cells (MSCs). This work optimizes the formulation of the hydrogel for maximum viability of MSCs and relatively higher cytoskeletal protein expression. The viability of cells is not affected due to electrical stimulation (ES). Further, ES alters the trophic factor secretion of MSCs, with significant increase in VEGF pathway genes—VEGFA and HSPB1. In addition, substrate stiffness of the hydrogel enhances the VEGFB secretion compared to control. Hence, the conducting polymer hydrogel system creates a tunable physical and electrical niche to enhance the therapeutic potential of stem cells for neurological injuries.
- Open Access
- 15 March 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-11
Electrical modulation of transplanted stem cells improves functional recovery in a rodent model of stroke
Stroke is a leading cause of long-term disability worldwide, intensifying the need for effective recovery therapies. Stem cells are a promising stroke therapeutic, but creating ideal conditions for treatment is essential. Here we developed a conductive polymer system for stem cell delivery and electrical modulation in animals. Using this system, electrical modulation of human stem cell transplants improve functional stroke recovery in rodents. Increased endogenous stem cell production corresponds with improved function. Transcriptome analysis identified stanniocalcin 2 (STC2) as one of the genes most significantly upregulated by electrical stimulation. Lentiviral upregulation and downregulation of STC2 in the transplanted stem cells demonstrate that this glycoprotein is an essential mediator in the functional improvements seen with electrical modulation. Moreover, intraventricular administration of recombinant STC2 post-stroke confers functional benefits. In summation, our conductive polymer system enables electrical modulation of stem cells as a potential method to improve recovery and identify important therapeutic targets.
- 15 March 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-11
Open AccessElectrical modulation of transplanted stem cells improves functional recovery in a rodent model of stroke
Stroke is a leading cause of long-term disability worldwide, intensifying the need for effective recovery therapies. Stem cells are a promising stroke therapeutic, but creating ideal conditions for treatment is essential. Here we developed a conductive polymer system for stem cell delivery and electrical modulation in animals. Using this system, electrical modulation of human stem cell transplants improve functional stroke recovery in rodents. Increased endogenous stem cell production corresponds with improved function. Transcriptome analysis identified stanniocalcin 2 (STC2) as one of the genes most significantly upregulated by electrical stimulation. Lentiviral upregulation and downregulation of STC2 in the transplanted stem cells demonstrate that this glycoprotein is an essential mediator in the functional improvements seen with electrical modulation. Moreover, intraventricular administration of recombinant STC2 post-stroke confers functional benefits. In summation, our conductive polymer system enables electrical modulation of stem cells as a potential method to improve recovery and identify important therapeutic targets.